Apellis Pharmaceuticals Inc. (1JK)
Market Closed
15 May, 20:00
XFRA 
€
34. 11
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
10 Volume
-4.51 Eps
€ 34.11
Previous Close Want to track 1JK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
1JK Earnings Reports FAQ
What is the earnings per share (EPS) for 1JK?
The current EPS is -4.51.
What is the company's earnings growth rate?
Apellis Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Apellis Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Apellis Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 1JK at this time, as Apellis Pharmaceuticals Inc has no recent EPS data to calculate it.
